MedPath

Translational Study for Obesity Management in Mexican Adults Using the "Group Lifestyle Balance Program"

Not Applicable
Conditions
Obesity
Overweight
Interventions
Behavioral: Group Lifestyle Balance Program
Registration Number
NCT02537704
Lead Sponsor
Universidad de Sonora
Brief Summary

Obesity is the main modifiable risk factor for the development of chronic diseases in Mexico. Several randomized controlled trials have shown that intensive lifestyle programs are efficacious for the management of obesity. These programs include frequent sessions (14 or more contacts in the first 6 months) focused on diet and physical activity and use a behavior change protocol. In Mexico most primary care clinics and public hospitals apply traditional treatments for obesity management, which have limited effect on weight loss. This study would provide scientific evidence for an effective model for obesity management. Objective. The purpose of this study is to evaluate the effectiveness of the "Group Lifestyle Balance Program" for overweight and obesity management in adults, in primary care clinics and public hospitals from Sonora. This is a translational clinical study. Healthcare providers from the participating clinics will be trained with the Group Lifestyle Balance Program before its implementation. The primary outcome measurement is the change in body weight from baseline to 6 months and 12 months. Changes in body mass index, waist circumference, systolic and diastolic blood pressure, depression, quality of life and stress scales will be measured in patients receiving the program before and 6 and 12 months after starting the program. Additionally, biochemical parameters (fasting glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, fasting insulin, Homeostatic Model Assessment- Insulin Resistance (HOMA-IR) and liver enzymes \[Aspartate transaminase (AST), Alanine Aminotransferase (ALT)\] will be evaluated from baseline to 12 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
258
Inclusion Criteria
  • Adults (>18 years of age and <65)
  • Overweight or Obese (BMI >25 kg/m2 y <50 kg/m2)
  • Availability and motivation to attend the intervention program
  • Patients who would benefit from participating in the program according to the health providers
  • Signing an informed consent
Exclusion Criteria
  • Medical conditions affecting body weight significantly
  • Pregnancy or nursing
  • Bariatric surgery
  • Being unable to participate in regular moderate physical activity
  • Blood pressure >160 mm/Hg
  • HbA1c>9

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Group Lifestyle Balance ProgramGroup Lifestyle Balance ProgramParticipants will be assigned to an adaptation of the "Group Lifestyle Balance Program", a behavioral curriculum implemented in the Diabetes Prevention Program Study. The Group Lifestyle Balance Program will be provided weekly for the first 3.5 months, bi-weekly from 3.5 to 6 months and then monthly until 12 months. Health care providers will be trained for the implementation of the intervention. Additionally, participants will attend at least one monthly visit with a nutritionist (individually). The lifestyle objectives for participants will be as follows: 1. To lose 5-10% of initial weight through healthy eating. 2. To do 150 minutes of physical activity each week.
Primary Outcome Measures
NameTimeMethod
Change in body weightChange in body weight from baseline to 6 months and change in body weight from baseline to 12 months
Secondary Outcome Measures
NameTimeMethod
Change in HDL-cholesterolChange in HDL-cholesterol from baseline to 12 months
Change in triglyceridesChange in triglycerides from baseline to 12 months
Change in the Beck Depression Inventory scoreChange in the Beck Depression Inventory score from baseline to 6 months and change in in the Beck Depression Inventory score from baseline to 12 months
Change in total cholesterolChange in total colesterol from baseline to 12 months
Change in fasting insulinChange in fasting insulin from baseline to 12 months
Change in liver enzymes [AST and ALT]Change in liver enzymes [AST and ALT] from baseline to 12 months
Change in the Short Form-36 Health Survey scoreChange in the Short Form-36 Health Survey score from baseline to 6 months and change in the SF-36 Health Survey score from baseline to 12 months
Change in fasting glucoseChange in fasting glucose from baseline to 12 months
Change in HOMA-IRChange in HOMA-IR from baseline to 12 months
Change in waist circumferenceChange in waist circumference from baseline to 6 months and change in waist circumference from baseline to 12 months
Change in body fat percentageChange in body fat percentage from baseline to 6 months and change in body fat percentage from baseline to 12 months
Change in the Perceived Stress Scale (PSS) -14 scoreChange in the Perceived Stress Scale (PSS) -14 score from baseline to 6 months and change in the Perceived Stress Scale PSS-14 score from baseline to 12 months
Change in systolic and diastolic blood pressureChange in systolic and diastolic blood pressure from baseline to 6 months and change in systolic and diastolic blood pressure from baseline to 12 months
Change in LDL-cholesterolChange in LDL-cholesterol from baseline to 12 months

Trial Locations

Locations (5)

Centro de Salud Urbano Dr. Domingo Olivares

馃嚥馃嚱

Hermosillo, Sonora, Mexico

Hospital General del Estado de Sonora

馃嚥馃嚱

Hermosillo, Sonora, Mexico

Centro Avanzado de Atenci贸n a la Salud (CAAPS)

馃嚥馃嚱

Hermosillo, Sonora, Mexico

Centro de Promoci贸n de Salud Nutricional (CPSN)

馃嚥馃嚱

Hermosillo, Sonora, Mexico

Hospital Ignacio Ch谩vez

馃嚥馃嚱

Hermosillo, Sonora, Mexico

漏 Copyright 2025. All Rights Reserved by MedPath